BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2457861)

  • 1. The HBV X-ORF encodes a transactivator: a potential factor in viral hepatocarcinogenesis.
    Zahm P; Hofschneider PH; Koshy R
    Oncogene; 1988 Aug; 3(2):169-77. PubMed ID: 2457861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state.
    Wollersheim M; Debelka U; Hofschneider PH
    Oncogene; 1988 Nov; 3(5):545-52. PubMed ID: 2856254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator.
    Kekulé AS; Lauer U; Meyer M; Caselmann WH; Hofschneider PH; Koshy R
    Nature; 1990 Feb; 343(6257):457-61. PubMed ID: 2153938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of X protein on transactivation of hepatitis B virus promoters and on viral replication.
    Nakatake H; Chisaka O; Yamamoto S; Matsubara K; Koshy R
    Virology; 1993 Aug; 195(2):305-14. PubMed ID: 8337816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transactivation of cellular gene expression by hepatitis B viral proteins: a possible molecular mechanism of hepatocarcinogenesis.
    Caselmann WH
    J Hepatol; 1995; 22(1 Suppl):34-7. PubMed ID: 7602073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synergistic transactivation of the hepatitis B viral (HBV) pregenomic promoter by the E6 protein of human papillomavirus type 16 (HPV-16 E6) with HBV X protein was mediated through the AP1 site of E element in the enhancer I (EnI) in human liver cell.
    Lee DH; Choi BH; Rho HM
    Biochem Biophys Res Commun; 1999 Nov; 265(1):62-6. PubMed ID: 10548491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the role of individual protein binding motifs within the hepatitis B virus enhancer I on X promoter activity using linker scanning mutagenesis.
    Gustin K; Shapiro M; Lee W; Burk RD
    Virology; 1993 Apr; 193(2):653-60. PubMed ID: 8384750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transactivation of cellular promoters by an integrated hepatitis B virus DNA.
    Yamamoto S; Nakatake H; Kawamoto S; Takimoto M; Koshy R; Matsubara K
    Biochem Biophys Res Commun; 1993 Apr; 192(1):111-8. PubMed ID: 8476412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic potential of hepatitis B virus.
    Koike K; Shirakata Y; Yaginuma K; Arii M; Takada S; Nakamura I; Hayashi Y; Kawada M; Kobayashi M
    Mol Biol Med; 1989 Apr; 6(2):151-60. PubMed ID: 2615644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4.
    Lee YI; Lee S; Lee Y; Bong YS; Hyun SW; Yoo YD; Kim SJ; Kim YW; Poo HR
    Oncogene; 1998 May; 16(18):2367-80. PubMed ID: 9620554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HBV integrants of hepatocellular carcinoma cell lines contain an active enhancer.
    Shamay M; Agami R; Shaul Y
    Oncogene; 2001 Oct; 20(47):6811-9. PubMed ID: 11687960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The conserved amino-terminal region (amino acids 1-20) of the hepatitis B virus X protein shows a transrepression function.
    Misra KP; Mukherji A; Kumar V
    Virus Res; 2004 Oct; 105(2):157-65. PubMed ID: 15351489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a specific region in the hepatitis B virus enhancer I for the efficient expression of X gene in the hepatic cell.
    Fukai K; Takada S; Yokosuka O; Saisho H; Omata M; Koike K
    Virology; 1997 Sep; 236(2):279-87. PubMed ID: 9325235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. trans-activation of viral enhancers by the hepatitis B virus X protein.
    Spandau DF; Lee CH
    J Virol; 1988 Feb; 62(2):427-34. PubMed ID: 2826805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatoma-derived integrated HBV DNA causes multi-stage transformation in vitro.
    Luber B; Arnold N; Stürzl M; Höhne M; Schirmacher P; Lauer U; Wienberg J; Hofschneider PH; Kekulé AS
    Oncogene; 1996 Apr; 12(8):1597-608. PubMed ID: 8622879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfer and expression of plasmids containing human cytomegalovirus immediate-early gene 1 promoter-enhancer sequences in eukaryotic and prokaryotic cells.
    Davis MG; Huang ES
    Biotechnol Appl Biochem; 1988 Feb; 10(1):6-12. PubMed ID: 2841949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transactivating function of integrated hepatitis B virus.
    Yamamoto S; Mita E; Nakatake H; Takimoto M; Koshy R; Matsubara K
    Biochem Biophys Res Commun; 1993 Dec; 197(3):1209-15. PubMed ID: 8280135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The identification of hepatitis B virus X gene responsive elements reveals functional similarity of X and HTLV-I tax.
    Faktor O; Shaul Y
    Oncogene; 1990 Jun; 5(6):867-72. PubMed ID: 2359621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
    Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
    J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interaction of p53 with p53 response element like binding sequence at upstream of hepatitis B virus enhancer I].
    Qu JH; Zhu MH; Lin J; Ni CR; Li FM; Zhu Z; Yu GZ
    Ai Zheng; 2004 May; 23(5):502-7. PubMed ID: 15142443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.